Acumen Pharmaceuticals, Inc. (ABOS) has a market capitalization of $162.34M and trades at $2.68. The 52-week range is 0.855-3.6.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.3, Earnings Per Share (EPS) of $-2.00.
The stock has a beta of 0.34, operates in the Healthcare sector.
